Skin News and Research

RSS

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.

11 Mar 2011

Personal usage and patient recommendations for dietary supplements are quite common across specialties

For physicians within several medical specialties, including dermatology, cardiology and orthopedics, personal usage of and patient recommendations for dietary supplements are quite common-, according to a study published in Nutrition Journal, a peer-reviewed, on-line journal that focuses on the field of human nutrition.

11 Mar 2011

Murad launches new powerhouse anti-aging treatment product

Murad, Inc. has announced the launch of Complete Reform with Glyco Firming Complex, the latest powerhouse anti-aging treatment product in the company's award-winning Age Reform line.

11 Mar 2011

NCI report: Number of US cancer survivors increases to 11.7 million during 2007

The number of cancer survivors in the United States increased to 11.7 million in 2007, according to a report released by the Centers for Disease Control and Prevention and the National Cancer Institute, part of the National Institutes of Health. There were 3 million cancer survivors in 1971 and 9.8 million in 2001.

10 Mar 2011

Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.

10 Mar 2011

Ohio officials seek federal permission for use of propoxur to halt bedbug infestations

Mom's comforting tuck-them-in-words - "Sleep tight, don't let the bedbugs bite"- is becoming an impossible dream for millions of people as the world experiences a resurgence of an ancient scourge that is fostering human misery, financial burdens and the risk of exposure to potentially toxic materials. That's the message from the cover story of the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

10 Mar 2011

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.

10 Mar 2011

Immunologists identify key cell component that triggers allergic responses to cat dander

A breakthrough by scientists at The University of Nottingham could provide hope for any allergy sufferers who have ever had to choose between their health and their household pet.

10 Mar 2011

NCPA encourages patients on safe disposal of unwanted medications

In recognition of Patient Safety Awareness Week, the National Community Pharmacists Association encourages patients to properly dispose of expired or unwanted medications at a local independent community pharmacy as part of its Dispose My Meds program.

10 Mar 2011

Older men have higher risk of melanoma: Australian study

Health experts warn that the rates of skin cancer – melanoma, is on the rise among elderly Victorians. This came out as new figures were released yesterday by Cancer Council Victoria that showed that Victorians aged over 55 accounted for two-thirds of melanoma diagnoses, and rural men were at highest risk. In 2008 a total of 2217 Victorians were diagnosed with melanoma and 279 people died. Skin cancer rates have increased by 400 per cent in the past 26 years among older males.

9 Mar 2011

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

The U.S. Food and Drug Administration today approved Benlysta to treat patients with active, autoantibody-positive lupus who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.

9 Mar 2011

MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting

A year after its launch, the first dermatologist-driven company dedicated to primary skin cancer protection and prevention introduced its newest solar protection product -- a much-anticipated tinted mineral gel sunscreen – at the 2011 AAD meeting in New Orleans.

9 Mar 2011

UH conducts first ever pilot study to test heat therapy for treatment of PE

University Hospitals Case Medical Center is conducting the first ever pilot study to test a new procedure using "heat therapy" or local radiofrequency energy to treat premature ejaculation.

9 Mar 2011

Survey: Most HIV-positive patients die of cancer

Most HIV-positive patients die of cancer. In the latest issue of Deutsches Ärzteblatt International, Manfred Hensel's research group presents epidemiological data.

9 Mar 2011

Therapeutic potential of iPS cells may be limited by reprogramming errors and genomic instability

In the past few months, a slew of papers have indicated that the therapeutic potential of a promising type of stem cell, called induced pluripotent stem (iPS) cells, might be limited by reprogramming errors and genomic instability. iPS cells are engineered by reprogramming fully differentiated adult cells, often skin cells, back to a primitive, embryonic-like state.

9 Mar 2011

Study: Roundworm protein can suppress inflammation in patients with sepsis

Research by the University of Liverpool has found that systemic inflammation caused by sepsis can be suppressed by a protein which occurs naturally in a type of roundworm.

8 Mar 2011

Treatment with sildenafil significantly reduces RP in patients with scleroderma

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis, also known as scleroderma.

8 Mar 2011

Lab made urinary tube going strong after six years of transplant

In a scientific breakthrough, five boys who were unable to urinate due to pelvic injury were cured for up to six years after getting new lab-grown urethras or urinary tubes that connect with the bladder. This breakthrough comes from Wake Forest University researcher Anthony Atala. It was in 2006 that the team reported the first successful implantation of lab-grown urinary bladders into humans. Today six years after the operation all of the boys continue to do well, with normal or near-normal urinary flow. The boy first treated is now 16 years old and received his lab-grown urethra over six years ago.

8 Mar 2011

Mississippi researchers work on drug discovey for poison ivy skin rash

Each year nearly 50 million Americans develop an annoying skin rash after coming in contact with poison ivy. But University of Mississippi researchers are working on a pharmaceutical product to rein in the allergic reaction in people already sensitive to the plants and prevent it altogether in those who aren't.

8 Mar 2011

New advance in tissue engineering

Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center and colleagues reported today on a new advance in tissue engineering.

8 Mar 2011